Related Experiment Videos
Head activator as a potential serum marker for brain tumour analysis
M Winnikes1, H C Schaller, W Sachsenheimer
1Center for Molecular Neurobiology II, Hamburg, F.R.G.
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1992
Summary
Head activator (HA) levels in the blood can help diagnose brain tumors. Post-surgery HA levels indicate successful tumor removal, aiding in monitoring cancer progression and relapse.
Area of Science:
- Neuro-oncology
- Biomarker Discovery
- Clinical Diagnostics
Background:
- Elevated head activator (HA) levels are observed in specific human brain tumors, particularly those originating from neuroectodermal or neural crest cells.
- Tumors can release significant amounts of HA into circulation, leading to substantially increased serum concentrations.
Purpose of the Study:
- To investigate the diagnostic utility of serum head activator (HA) levels for brain tumor analysis.
- To evaluate HA as a potential serum marker for monitoring tumor progression, surgical success, and recurrence.
Main Methods:
- Serum HA levels were measured in patients before and after surgical intervention for brain tumors.
- Comparisons were made between pre- and post-surgical HA levels to assess the impact of tumor resection.
Main Results:
- Complete tumor removal correlated with a return of HA serum levels to normal ranges post-surgery.
- Incomplete tumor resection led to a significant decrease in HA levels, but not to normalization.
- Surgical procedures themselves did not affect HA serum levels in patients with initially normal levels.
Conclusions:
- Serum HA is a promising biomarker for monitoring brain tumor status.
- HA levels can effectively indicate successful tumor removal and aid in detecting tumor relapse.
- This marker holds potential for tracking disease progression in neuro-oncology patients.